An Essential Overview of the Pharmaceutical and Biotech Industries

This programme will give you an invaluable overview of the Pharmaceutical industry, from discovery of the molecule through development to marketing

21 Oct 2019

& 4 May 2020 , 23 Oct 2020

GBP 699
EUR 979
USD 1,090

Book now

Course overview

This programme will give you an invaluable overview, refresher and update on the pharmaceutical and biotechnology industries, from discovery of the molecule through development to marketing. It will provide a step-by-step understanding of the main areas of drug development and will discuss the roles and responsibilities of key staff involved. You will be given a comprehensive glossary of the most commonly used industry terms, which will be an invaluable reference to help you get to grips with the technical terminology and jargon.

Book both

This meeting runs back-to-back with An Essential Overview of the Medical Devices Industry and there is a further £100/€140 discount when booked with An Essential Overview of the Pharmaceutial and Biotech Industries.

To register on both events click HERE

To find out more call Customer Services on +44 (0)20 7749 4730 or e-mail info@management-forum.co.uk

Who should attend

All those wanting to achieve a better understanding of how the pharma/biotech industries work. The course will be particularly helpful for those wanting to understand what other departments do, for new staff working in the industry and for non-scientific and administrative personnel.

Why you should attend

  • Increase your understanding of the pharma/biotech industries
  • Develop your knowledge of the stages of drug development from drug discovery through to marketing
  • Get to grips with the phases of clinical trials, regulatory processes and pharmacovigilance requirements
  • Understand the roles and responsibilities of key departments and how they work together
  • Demystify the technical terminology and jargon

Programme

How the pharma/biotech industries develop medicines

  • Overview of drug development
  • Framework of the industry – research, development and manufacture of pharma products on an international level
  • Difference between pharma and biotech drug development • Drug discovery
  • Non-clinical/pre-clinical – the importance of examining safety • Technologies and innovations across the industry
  • Strategy and the targeted product profile

Demystifying the jargon and terminology

Roles and responsibilities of the people in the pharma/biotech industries

Clinical trials

  • Phases of clinical research – phase 1 to phase IV and range of clinical trials
  • Setting up and running of clinical trials
  • Quality of the data – monitoring, auditing and compliance with GCP innovations in running clinical trials

Pharmacovigilance

  • Understanding pharmacovigilance
    • Safety reporting and signal detection
    • Evaluation and risk management plans – Periodic and drug safety update reports

Regulatory processes

  • Overview of regulatory submissions and approval procedures for pharma/biotech products
  • EU and FDA accelerated procedures
  • The importance of ICH
  • ICH and the electronic Common Technical Document (eCTD)
  • The EU Clinical Trial Regulation
  • Update on the impact of Brexit

Commercial considerations for how medicines are marketed and sold

  • Marketing terminology and activities

Presenter

Laura Brown

Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.

Book now

21 Oct 2019
21 Oct 2019 Rembrandt Hotel, London GBP 699.00
EUR 979.00
USD 1,090.00
+ VAT @ 20.00%
Enrol now
4 May 2020
4 May 2020 Rembrandt Hotel, London GBP 699.00
EUR 979.00
USD 1,090.00
+ VAT @ 20.00%
Enrol now
23 Oct 2020
23 Oct 2020 Venue not yet confirmed
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • Abbott Products Operations AG
  • Arriello Ireland Limited
  • Bayer Consumer Care AG
  • Bayer Public Limited Company
  • Brecon Anderson UK Ltd
  • British Society for Rheumatology
  • Charles Russell Speechlys LLP
  • Chugai Pharma UK Ltd
  • Datapharm Communications Ltd
  • F Hoffmann La Roche Ltd
  • Galderma R&D
  • Gilead Sciences
  • GW Pharmaceuticals
  • Intercept Pharma Europe Ltd
  • Intercept Pharmaceuticals
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Norgine
  • ONO Pharma
  • Pharmiweb Solutions
  • Presspart
  • Probiotics International Ltd.
  • Ridge Pharma
  • Shire Pharmaceuticals
  • Sunovion Pharmaceuticals Europe
  • TauRx Therapeutics Ltd
  • Toxikon Europe NV
  • UCB BIOSCIENCES GmbH
  • UCB Pharma SA
  • UCL
  • Vertex Pharmaceuticals (Europe) Limited

The speaker was very engaging, easy to listen to and made the course content easy to understand for newcomers - no jargon!

Tasmin Morgan, Operations Manager, Ridge Pharma

Laura was very attentive to the delegates' diverse work experiences and expectations and so knowledgeable!

Catherine Jeannot, Language Teacher-Pharmacy Faculty, Université Paris Sud

The course was well organised, covered all areas of interest. The speaker had a lot of knowledge on the subject and she delivered the information well.

Yulia Degtyareva, Scientist, Philips

A clear presentation . Speaker was pertinent and has an expert knowledge in pharmaceutical industry, updates the current events

Lingling DAI, Business Development Manager, LFB Biomedicament

I found the course very informative and enjoyable, Laura was very knowledgeable and made everything easy to understand.

Emily MacKenzie, Sponsorship and Partnerships Manager, British Society for Rheumatology

Very well organised course, with a very knowledgable and friendly presenter giving clear and concise information. Very useful to people new to the industry and a good revision for others.

Shona Rhydderch, Analytical Chemist, TauRx Therapeutics Ltd

Very enjoyable overall, I feel this will help my learning and development

Tanya Killick, Medical Administrative Associate, Vertex Pharmaceuticals (Europe) Limited

All areas were excellent. The booklet accompanying the presentation was very helpful

Grace McIntyre, Warehouse Technician, GW Pharmaceuticals

Very good content, engaging speaker

Yasmin Hubbard, Admin Associate III, International Medical Affairs, Vertex Pharmaceuticals (Europe) Limited

Very informative. The speaker kept everyone engaged by involving them in group task was a good way to interact and learn more about other areas of the industry

Kit Graham, Warehouse Operative, GW Pharm

The course was great, well prepared and well spoken.

Monica Milani, Redacteur Scientifique , GALDERMA Recherche & Developpement

Overall I am very happy with the course

Paul Fitton, Regulatory Affairs Specialist, Presspart

I felt that a newbie to Pharmaceuticals it was a perfect course for me to have a overview without being too complicated. There was a lot to cover and I think Laura delivered the course well and was happy to answer questions when asked.

Sharon Shoveller, Supply Chain Distribution Administrator, GW Pharma Ltd

Excellent, best course I have been on to date

Sharna King, , G Pharm

I thought the course was good and I liked the fact that we was able to get to work with different people. The presentation was good, it was broken down step by step to give everyone a better understand and it was very easy to follow. The speaker was very professional.

Cher Kelly, Document Control Assistant , GW pharma

Very good course- I would recommend to my colleagues

Hayley West, Preclinical Coordinator , GW Pharmaceuticals

The course was insightful and carefully structured. The presentation was basic and effective through powerpoint. The speaker was excellent, clear and concise.

Dhirenkumar Mistry, Marketing, Arriello Ireland Limited

The content and presentation were interesting and followed a logic pattern. The speaker was very clear and engaging.

Quazi Hussain, Vigilance Risk Management Student Placement, Mundipharma Research Limited

Very good content, but not enough time to discuss in more details, or to ask more questions

Sophie Ferruit, Scientific writer, Monachem

All areas well covered, all questions answered. Pleasant speaker.

Leanne Gosling, , Bayer

I thought the content was appropriate and very well presented but there was a lot to cover in one day. I thought Laura was excellent and presented very well and I thought the execution of the event was run smoothly and efficiently by Management Forum.

Susan Delaney, National Scientific Advice Administrator, Medicines and Healthcare Products Regulatory Agency (MHRA)